Home/Filings/4/0001209191-23-025473
4//SEC Filing

MACARTNEY LAWSON 4

Accession 0001209191-23-025473

CIK 0001607678other

Filed

Apr 23, 8:00 PM ET

Accepted

Apr 24, 7:31 PM ET

Size

8.6 KB

Accession

0001209191-23-025473

Insider Transaction Report

Form 4
Period: 2023-04-24
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.00001 per share

    2023-04-24$3.33/sh+16,000$53,28063,965 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-04-2416,0000 total
    Exercise: $3.33From: 2017-01-04Exp: 2026-01-04Common Stock (16,000 underlying)
  • Sale

    Common Stock, par value $0.00001 per share

    2023-04-24$22.00/sh16,000$352,06147,965 total
Footnotes (1)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Issuer

Viking Therapeutics, Inc.

CIK 0001607678

Entity typeother

Related Parties

1
  • filerCIK 0001606831

Filing Metadata

Form type
4
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 7:31 PM ET
Size
8.6 KB